Sort
38,696 grants matching “als”
ACTIVITY-DRIVEN PLASTICITY OF THE HAIR CELL CYTOSKELETON
$432,748Alejandra Catalina Velez Ortega · University Of Kentucky · R01 · FY2024 · DC
Central States Criminal Justice Drug Abuse Center
$432,734Carl G Leukefeld · University Of Kentucky · U01 · FY2007 · DA
Development of statistical genetics methodology
$432,702Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2018 · HG
Structural Biology of Amyloid Disease
$432,690David Eisenberg · University Of California Los Angeles · R01 · FY2008 · AG
BCR signaling during B cell development and maintenance
$432,671Michael Craig Carroll · Immune Disease Institute, Inc. · R37 · FY2012 · AI
Bio-Organic Biomedical Mass Spectromy Resource
$432,540Alma L Burlingame · University Of California, San Francisco · P41 · FY2012 · GM
Nortriptyline-mediated attenuation of alpha-synuclein pathology in Parkinson's disease
$432,538Timothy J. Collier · Michigan State University · R01 · FY2019 · NS
Defining Immune Cell Heterogeneity in Human ALS and Mouse Model of the Disease
$432,521Serge E Przedborski · Columbia University Health Sciences · R01 · FY2024 · NS
Blood vessel assembly from multipotent hemangioma-derived stem cells
$432,500Joyce E. Bischoff · Boston Children'S Hospital · R01 · FY2011 · HL
Neurobiology of Aggression Comorbidity in Autism
$432,500Matthew P Anderson · Beth Israel Deaconess Medical Center · R01 · FY2017 · MH
Neurobiology of Aggression Comorbidity in Autism
$432,500Matthew P Anderson · Beth Israel Deaconess Medical Center · R01 · FY2020 · MH
Neurobiology of Aggression Comorbidity in Autism
$432,500Matthew P Anderson · Beth Israel Deaconess Medical Center · R01 · FY2019 · MH
Neurobiology of Aggression Comorbidity in Autism
$432,500Matthew P Anderson · Beth Israel Deaconess Medical Center · R01 · FY2018 · MH
Neurobiology of Aggression Comorbidity in Autism
$432,500Clifford B Saper · Beth Israel Deaconess Medical Center · R01 · FY2021 · MH
Novel Therapy for Amyotrophic Lateral Sclerosis
$432,496David E Smith · Angion Biomedica Corporation · R44 · FY2010 · NS
âRegulation of Protein Quality Control by the VCP AAA-ATPaseâ
$432,441Malavika Raman · Tufts University Boston · R01 · FY2021 · GM
Role of Advanced Screening Technologies in Early Detection of Breast Cancer
$432,434Sandra J Lee · Dana-Farber Cancer Inst · RC1 · FY2009 · CA
Tick Gut Immunome- Gut Microbiota Interactions in the Context of Tick-Borne Pathogens
$432,375Erol Fikrig · Univ Of Maryland, College Park · P01 · FY2018 · AI
Deficits in KCC2 activity and the pathophysiology of Status Epilepticus
$432,347Stephen J Moss · Tufts University Boston · R01 · FY2015 · NS
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer
$432,302David Danforth · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Project 3
$432,289Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2023 · NS
Pineal Regulation: Molecular basis of development
$432,211David Klein · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Dynamics of Vocal Tract Shaping
$432,151Shrikanth Narayanan · University Of Southern California · R01 · FY2012 · DC
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer
$432,142David Danforth · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Arginase and Regulation of Nitric Oxide Synthase in ALS
$432,140Beth Israel Deaconess Medical Center · R01 · FY2002 · NS